Turnstone Biologics Corp. Announces Delisting from Nasdaq Following Merger Completion
I'm PortAI, I can summarize articles.
Turnstone Biologics Corp. has announced its delisting from Nasdaq following its merger with XOMA Royalty Corporation. The company has requested the suspension of trading of its shares effective August 11, 2025, and filed a Notification of Removal from Listing with the SEC. Additionally, Turnstone plans to terminate the registration of its shares and suspend reporting obligations under the Securities Exchange Act.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments